Guangxi Liuzhou Pharm Co Ltd - Asset Resilience Ratio
Guangxi Liuzhou Pharm Co Ltd (603368) has an Asset Resilience Ratio of 1.77% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore Guangxi Liuzhou Pharm Co Ltd asset portfolio for the complete picture of this company's asset base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2023)
This chart shows how Guangxi Liuzhou Pharm Co Ltd's Asset Resilience Ratio has changed over time. See 603368 equity financing ratio to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Guangxi Liuzhou Pharm Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Guangxi Liuzhou Pharm Co Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥390.82 Million | 1.77% |
| Total Liquid Assets | CN¥390.82 Million | 1.77% |
Asset Resilience Insights
- Limited Liquidity: Guangxi Liuzhou Pharm Co Ltd maintains only 1.77% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Guangxi Liuzhou Pharm Co Ltd Industry Peers by Asset Resilience Ratio
Compare Guangxi Liuzhou Pharm Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jointown Pharmaceutical Group Co Ltd
SHG:600998 |
Medical Distribution | 0.08% |
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
|
Cyclopharm Ltd
AU:CYC |
Medical Distribution | 1.98% |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607 |
Medical Distribution | 4.21% |
Annual Asset Resilience Ratio for Guangxi Liuzhou Pharm Co Ltd (2017–2023)
The table below shows the annual Asset Resilience Ratio data for Guangxi Liuzhou Pharm Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 1.60% | CN¥322.20 Million ≈ $47.15 Million |
CN¥20.16 Billion ≈ $2.95 Billion |
+0.83pp |
| 2018-12-31 | 0.77% | CN¥75.00 Million ≈ $10.97 Million |
CN¥9.77 Billion ≈ $1.43 Billion |
-3.87pp |
| 2017-12-31 | 4.63% | CN¥350.00 Million ≈ $51.22 Million |
CN¥7.55 Billion ≈ $1.11 Billion |
-- |
About Guangxi Liuzhou Pharm Co Ltd
Guangxi LiuYao Group Co., Ltd engages in the wholesale and retail of pharmaceutical products in China. It offers various types of medicines, medical devices, consumables, and test reagents through online pharmacies and terminal physical pharmacies. The company was founded in 1981 and is based in Liuzhou, China.